Director's Estate Owning Company Shares: IHT Valuation Battles
- MAZ
- 1 day ago
- 13 min read
Director's Estate Owning Company Shares: IHT Valuation Battles in the UK
When a director dies holding shares in a private limited company, those shares must be valued for Inheritance Tax at their open market value as at the date of death under section 160 of the Inheritance Tax Act 1984. That value is rarely agreed without some degree of negotiation with HMRC's Shares and Assets Valuation team, and since the Business Property Relief cap was introduced from April 2026, the financial consequences of getting the valuation wrong have increased considerably.
How HMRC Values Unquoted Company Shares for IHT
The Open Market Value Standard
The statutory test is the price the shares might reasonably be expected to fetch if sold in the open market at the date of death. That hypothetical open market is populated by a willing and fully informed hypothetical purchaser, and the price is unaffected by any actual supply constraint, such as the fact that no one in reality would want to buy a small shareholding in a private company with no exit in sight.
This hypothetical nature of the valuation is central to understanding why disputes arise. There is no published price to look up. The valuer, whether acting for the executors or on behalf of HMRC, must construct the value from first principles using financial analysis, comparisons with similar companies, and professional judgement.
SAV: The Team and the Process
Shares and Assets Valuation (SAV) is a section of HMRC mainly dealing with the valuation of unquoted shares. SAV also provides specialist valuation advice to HMRC in respect of a variety of other assets including goodwill.
The practical sequence for an estate with private company shares runs as follows. The executors submit form IHT400 with accompanying schedules. Where business assets are involved, the relevant schedule requires a proposed valuation with supporting information. SAV reviews that submission, may request additional information, and will then typically open a correspondence process. At least 90% of valuations currently referred to SAV are agreed or settled within perhaps six months. However, that reflects the current profile of cases. Complex cases involving disputed methodology, significant minority discounts, or large amounts of tax at stake can take considerably longer.
The Most Contested Areas in Unquoted Share Valuations
Earnings Multiple: The Starting Point and the Battleground
For trading companies, the primary valuation method is an earnings multiple applied to maintainable profits. SAV constructs the earnings figure by taking the reported accounts, then normalising them for items that would not represent the ongoing profitability of the business: non-recurring income, one-off expenses, and adjustments to the director's remuneration.
That last adjustment is the one that consistently creates friction. If a director took a below-market salary from the company over many years, the accounts show higher profits than a comparable business with a market-rate employee in the same role would show. SAV will add a market-rate salary charge back against the profits when constructing maintainable earnings. Conversely, where a director was overpaid relative to their commercial contribution, the reverse adjustment applies.
The earnings multiple SAV applies is derived from comparable listed company transaction data, adjusted for size, private company illiquidity, and specific business risk factors. Getting the right multiple for a small professional services business, a manufacturing firm, or a specialist trade operation requires knowledge of sector benchmarks, and the range of defensible multiples for any given company is often wider than both sides would prefer to admit.
Minority Shareholdings and Discount Arguments
In the case of minority shareholders, certain discounts can be applied to the value of their interest in a business. This will depend on the business and the various rights and control exercised by relevant minority shareholders.
A minority shareholder has no ability to force a dividend, block a liquidation, or control management decisions. A hypothetical purchaser buying a 25% stake in a profitable but closely held company knows they will be a passenger, dependent on the majority for any return on their investment. That diminished economic position justifies a discount against the pro-rated value of the company.
SAV does not dispute that minority discounts exist. The dispute is about their size. Executors' valuers will sometimes argue for discounts of 30-40% or more on small minority stakes. SAV will typically offer considerably less, arguing that the discount already implied in the earnings multiple for a private company removes the need for a further significant reduction.
Where the deceased held a controlling interest, no minority discount applies. The valuation captures the full value of control, including any control premium a hypothetical purchaser would pay. The related property rule in section 161 IHTA 1984 can aggregate the shares held by the deceased with those held by their surviving spouse or civil partner for the purpose of determining whether a controlling interest is involved, which sometimes makes the valuation more contentious than a straightforward single-owner situation.
Personal Goodwill and Key Man Risk
The most genuinely complex valuation argument for director-owned businesses is the goodwill question. Some businesses are dependent on the personal relationships, technical expertise, or reputation of the director who has died. A hypothetical purchaser would factor this into the price they are prepared to pay for the shares, either by applying a lower multiple or by discounting the maintainable earnings figure to reflect anticipated loss of business post-death.
SAV resists large key man deductions on the grounds that a buyer making an offer for the company would already be factoring in key person risk when choosing their earnings multiple. The implicit risk premium embedded in a lower multiple is SAV's preferred way of capturing this, rather than a separate mathematical deduction. Where the deceased's relationships were the core of the business, such as in a client-facing professional practice, the argument for a more explicit adjustment is stronger, but substantiating it requires evidence: client concentration data, revenue attribution, and some basis for quantifying what the business would look like without that individual.
Surplus Cash and Excluded Assets
Cash and investment assets held in the company above the working capital required for the trade create a dual problem in valuations. SAV tends to add these to the trading value using a "sum of parts" approach: trade value plus excess cash. From the BPR perspective, these assets are likely to be excluded assets under section 112 IHTA 1984 because they are not used wholly or mainly for the purposes of the trade.
The excluded assets analysis matters because BPR is denied on the portion of the company's value attributable to excluded assets. A company valued at £2 million, of which £400,000 represents surplus cash, may have BPR available on £1.6 million only. The valuation and the BPR analysis run in parallel, and the interaction can produce a larger than expected IHT liability where the company has accumulated cash over many years without distributing it.
Why the BPR Changes From April 2026 Make Valuations More Consequential
Before April 2026, a director holding 100% of an unquoted trading company with a clean BPR position faced a straightforward outcome: BPR at 100% eliminated the IHT charge entirely, and the valuation, while still technically required, had no direct tax consequence as long as BPR applied.
From April 2026, the BPR cap at £2.5 million means more unquoted share valuations will be negotiated with HMRC's Shares and Assets Valuation team, as the quantum of relief at stake rises materially. Valuation disputes for unquoted shares can take years to resolve, particularly where discount rates, comparable transactions, and methodology selection are contested.
Under the 2026/27 rules, BPR applies at 100% on the first £2.5 million of qualifying business assets per individual, and at 50% on qualifying business assets above that figure. For a company valued at £3 million, the first £2.5 million attracts 100% BPR and generates no IHT. The remaining £500,000 attracts 50% BPR, meaning £250,000 is chargeable to IHT at 40%, giving £100,000 of tax. A valuation argument that moves the agreed value from £3 million to £2.8 million, for example by successfully arguing a stronger minority discount or a larger key man deduction, reduces the taxable portion from £500,000 to £300,000, cutting the IHT bill from £100,000 to £60,000. On a case of that scale, engaging a specialist share valuer to contest SAV's position is cost-effective.
Changes announced at the last Budget mean that, from 6 April 2026, IHT charges could arise on assets that currently attract full BPR. Affected taxpayers should therefore be satisfied that, if required to do so by HMRC, they could justify the valuation placed on those assets for IHT purposes.
Director's Loan Accounts: A Separate Asset Often Overlooked
A director's loan account, representing money owed by the company to the deceased director at the date of death, is a separate asset in the estate. It is not part of the share value: it is a debt owed to the estate by the company, and it is valued separately at its face amount (adjusted for any irrecoverability if the company's financial position makes full recovery doubtful).
This distinction is consistently underestimated in estate administration. An estate where the deceased had £120,000 in a director's loan account and shares worth £800,000 has two separate IHT assets, not one composite business asset. The loan account does not qualify for BPR; only the shares themselves can qualify. Executors who combine the two into a single figure and apply BPR to the total are making a significant error that HMRC will identify.
The Dispute Process: What Executors Actually Experience
When SAV opens a valuation enquiry, the typical progression involves SAV requesting the last three to five years of accounts, management accounts if available, any recent professional valuations, details of the company's sector, and information about the shareholding structure. SAV will then produce its own valuation position, often significantly higher than the executors' valuation.
The gap between the two positions is then the subject of correspondence and negotiation. The time taken to agree valuations with SAV can be years if there are entrenched positions or there is a point of principle which HMRC wish to uphold. This may reflect differences of opinion of methodology, inputs to the methodologies, the discount, the meaning of the rights attaching to the shares, or the amount of tax which might be at stake.
Where agreement cannot be reached through correspondence, section 222 IHTA 1984 provides a statutory mechanism for referring the matter to the Upper Tribunal (Tax and Chancery Chamber) for determination. The tribunal process is formal, expensive, and time-consuming. Most disputes settle before reaching this point, often because both parties recognise the range of outcomes a tribunal could produce and prefer a certain agreed figure to an uncertain judicial determination.
The executors' obligation to pay IHT, and the six-month deadline for payment from the date of death to avoid interest, creates an immediate cashflow consideration even while valuation is disputed. Executors will usually pay estimated IHT based on their valuation and then seek a repayment or make an additional payment once the valuation is agreed. HMRC charges late payment interest at the Bank of England base rate plus 2.5% from the date payment was due, which is currently a meaningful rate.
What Can Be Done Before Death to Reduce Valuation Disputes
The time to address valuation uncertainty is before death, not after. Several steps taken during the director's lifetime can materially reduce the scope and cost of post-death disputes.
Obtaining a professional valuation of the shares every two to three years, prepared by a qualified independent valuer using the methodology SAV would apply, gives executors a defensible starting position and demonstrates that the estate was managed with proper regard to its IHT obligations. It also identifies surprises, such as excluded asset issues or trading company condition risks, at a point where corrective action is still possible.
Reviewing the company's balance sheet periodically to manage the excluded assets position is equally valuable. Surplus cash and investments accumulated in the company without any trading rationale are likely excluded assets. Paying dividends, making pension contributions through the company, or deploying excess cash into the trade before death can improve the BPR position and reduce the scope of any valuation dispute.
For shareholdings that may attract minority discounts, reviewing the articles of association and any shareholders' agreements to consider whether tag-along or drag-along rights, pre-emption provisions, or other features affect the marketability and value of the shares is a useful exercise. The terms attached to the shares affect the value a hypothetical purchaser would pay for them, and those terms can be structured during the director's lifetime.
Key Takeaways
The valuation of unquoted company shares for IHT is determined by reference to the open market value at the date of death, assessed by HMRC's Shares and Assets Valuation team. The methodology is earnings-based for trading companies, net asset based for investment companies, and subject to adjustments for maintainable earnings, minority discounts, and excluded assets.
From April 2026, the BPR cap at £2.5 million means more unquoted share valuations will be negotiated with HMRC's Shares and Assets Valuation team, as the quantum of relief at stake rises materially.
Director's loan accounts are a separate estate asset, not part of the share value, and do not qualify for BPR.
The valuation process can take months or years to conclude. Executors must pay estimated IHT within six months of death to avoid interest, and then resolve the valuation with SAV subsequently.
Pre-death planning, including periodic professional valuations, managing excluded assets, and reviewing the BPR qualifying conditions of the company, substantially reduces the scope and cost of post-death valuation disputes.
Q1: What makes valuing a director's shares in a private family company particularly contentious for Inheritance Tax purposes?
A1: Well, it's worth noting that unlike listed shares with daily prices, private company shares lack an obvious market value, so HMRC and executors often clash over what a willing buyer would pay. In my experience with clients, the battle intensifies around control premiums for majority stakes versus minority discounts for smaller holdings, sometimes 20-50% off for lack of marketability and influence. Consider a director in Manchester holding 55% of a trading firm: the estate might push for a lower valuation citing illiquidity, while HMRC argues for a higher figure based on recent profits and assets. Getting an independent valuation early, ideally from a specialist, can prevent nasty surprises and negotiations dragging on for months.
Q2: How do recent changes to Business Relief impact the valuation battles for directors' estates?
A2: In my practice, directors are increasingly concerned about the cap on full Business Relief, which affects how aggressively valuations are scrutinised. For estates after the relevant date in 2026, the first portion of qualifying business assets benefits from higher relief, but excess faces only 50%, meaning precise open market valuations become even more critical to minimise the taxable slice. I've seen family businesses in the Midlands where a slightly optimistic valuation on the full holding saved significant tax by staying under thresholds, but overdoing it invites HMRC challenges. Always factor in the two-year ownership rule and ensure the company qualifies as mainly trading, investment-heavy holdings can lose relief entirely.
Q3: Can a shareholders' agreement help resolve or prevent IHT valuation disputes in a director's estate?
A3: Absolutely, and in my experience, it's one of the smartest pre-emptive steps. A well-drafted agreement can include mechanisms for valuing shares on death, such as referencing independent experts or formulas tied to EBITDA multiples, which provides a defensible position for executors. I've advised Birmingham-based directors where the agreement specified a 'fair value' process, reducing HMRC pushback. However, watch out for binding contracts for sale clauses, as these can disqualify Business Relief. It's not a silver bullet, but it gives families clarity and can speed up probate while strengthening your negotiating hand.
Q4: What pitfalls arise when valuing minority shareholdings held by a director for their estate's IHT return?
A4: Minority holdings often lead to the biggest valuation battles because of discounts for lack of control. In practice, I've seen executors undervalue these too aggressively, prompting HMRC to demand uplifts based on comparable transactions or earnings potential. Take a tech director in Edinburgh with a 25% stake: without proper evidence of restrictions in the articles of association, the discount might shrink from 40% to 15%, inflating the IHT bill. The key is robust documentation, recent accounts, dividend history, and a professional report, and remembering that death itself can affect value if it triggers share transfer rules.
Q5: How should directors plan for potential CGT interactions following an IHT valuation of company shares?
A5: This is a common mix-up I encounter with clients. The IHT probate value generally becomes the base cost for future Capital Gains Tax when beneficiaries sell, but only if it's 'ascertained', meaning agreed with HMRC or determined by the courts. In one case with a London director's estate, a negotiated lower IHT valuation provided a helpful CGT uplift later, but it required careful coordination. Beneficiaries should keep detailed records, as mismatches can lead to unexpected tax on disposal. Early engagement with HMRC's Shares and Assets Valuation team often smooths this.
Q6: What role do excepted assets play in valuation disputes for a director-owned company's shares?
A6: Excepted assets, like surplus cash or investment properties not used in the trade, can complicate things significantly. HMRC may argue they should reduce the Business Relief-eligible value, leading to protracted debates on apportionment. From advising family firms, I've found that segregating these assets into separate entities beforehand often helps, but doing it late can look like artificial planning. A practical tip: review company balance sheets with your accountant well in advance to ensure the main trading operations dominate, supporting a cleaner valuation for the estate.
Q7: Is it possible to challenge HMRC's share valuation after submitting the IHT account, and how?
A7: Yes, and many of my clients have successfully done so. Start with a formal review request, backed by your own expert valuation report highlighting methodology differences, perhaps differing earnings capitalisation or discount rates. If that fails, an appeal to the Tax Tribunal is an option, though it requires strong evidence and can take time. In my experience, disputes over private company shares often settle through negotiation once comparables or industry data are presented. Don't delay; timely professional input is crucial, especially with liquidity issues in funding any additional tax.
Q8: How does a director's death affect the valuation of shares in a company with life assurance or buy-sell agreements?
A8: These arrangements can be double-edged. While life cover helps fund IHT, a pre-existing buy-sell agreement might be seen as a binding contract, potentially restricting Business Relief. I've worked with directors in the North West where updating agreements to 'option' structures rather than obligations preserved relief while providing liquidity. Valuations must consider the impact of any payout on the company's worth post-death, ignoring certain death-related changes but accounting for others. Reviewing these with a tax adviser is essential to avoid unintended consequences.
Q9: What considerations apply to directors holding shares through trusts in their estate planning?
A9: Trusts add layers to valuation battles, particularly around control and relief eligibility. For instance, shares in a discretionary trust might be valued differently, and Business Relief availability depends on the settlor's interest. In practice, I've seen cases where life interest trusts helped with IHT but complicated the open market value due to beneficiary rights. Directors should ensure trust deeds align with company articles and get specialist valuations for ten-year anniversary charges or exits. It's a powerful tool for succession but demands careful setup to withstand scrutiny.
Q10: How can directors of investment-leaning companies still navigate IHT valuation challenges effectively?
A10: Pure investment companies struggle with Business Relief, so valuations focus heavily on underlying assets, often leading to higher IHT exposure. That said, if the company has a trading element exceeding 50%, relief can apply, though HMRC tests this rigorously. One client, a property developer director, restructured to emphasise development activities, supporting a stronger valuation position. Practical advice: maintain clear records distinguishing trading from investment income, and consider AIM-listed options where available for partial relief. Proactive planning with an experienced adviser helps turn potential battles into managed outcomes.
About the Author
Maz Zaheer, AFA, MAAT, MBA, is the CEO and Chief Accountant of MTA and Total Tax Accountants, two premier UK tax advisory firms. With over 15 years of expertise in UK taxation, Maz provides authoritative guidance to individuals, SMEs, and corporations on complex tax issues. As a Tax Accountant and an accomplished tax writer, he is renowned for breaking down intricate tax concepts into clear, accessible content. His insights equip UK taxpayers with the knowledge and confidence to manage their financial obligations effectively.
Disclaimer:
The information provided in our articles is for general informational purposes only and is not intended as professional advice. While we strive to keep the information up-to-date and correct, MTA makes no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information, products, services, or related graphics contained in the articles for any purpose. Any reliance you place on such information is therefore strictly at your own risk. The graphs may also not be 100% reliable.
